A South Korea study suggested that in the non‐survival group, baseline levels of NLR, LDH, and CRP were higher, but only LDH and CRP levels were significant indicators for OS in NSCLC patients receiving immunotherapy [30]. Here, CRP is linked to non-small cell lung carcinoma.